OVERVIEW
 The healthcare sector is one of the largest and fastest-growing areas of the U.S. and global economies. Healthcare expenditures in the U.S. have outpaced overall economic growth in recent years, a trend that is expected to continue for the foreseeable future. This growth is being driven by a number of factors, including the aging of the "baby boom" generation, longer life expectancies, and the introduction and availability of new treatments. We believe that the continued strong demand for healthcare products and services will create attractive investment opportunities across a wide variety of industry sub-segments.

DIAMOND CASTLE EXPERIENCE
George Fotiades serves as Diamond Castle's Operating Partner in the healthcare sector. Mr. Fotiades has more than 30 years of senior-level operating experience at businesses in a variety of industry sub-segments, including Cardinal Health, Warner-Lambert, Bristol-Myers Squibb, Wyeth and Procter & Gamble.

Ari Benacerraf and David Wittels work with Mr. Fotiades in the healthcare sector.

AREAS OF FOCUS
Within the healthcare sector, Diamond Castle focuses on healthcare products, including pharmaceuticals, specialty pharmaceuticals, medical devices, equipment and supplies. We also focus on providers of services, such as manufacturing, marketing, distribution, information and business support services, to healthcare companies.

DIAMOND CASTLE INVESTMENTS
Managed Health Care Associates, Inc. Leveraged buyout of the largest Alternate Site GPO in the country servicing the Long Term Care, Home Infusion, Combo Pharmacy and Specialty Pharmacy industries. MHA facilitates over $3 billion of pharmaceutical purchases annually, and differentiates itself from traditional GPOs through its track record of innovation, powerful technology tools, high-touch service, extensive access to purchasing and dispensing data, industry education and advocacy, and commitment to enabling improved patient care.
REPRESENTATIVE PRIOR INVESTMENTS
WHILE AT DLJ MERCHANT BANKING
Accellent Inc. Growth capital investment to create the largest design, engineering and contract manufacturing company serving the medical device market.

Kinetic Concepts Inc.

Growth capital investment in a leading provider of wound care, pulmonary care, bariatric care and circulatory improvement products.
Charles River Laboratories $500 million leveraged buyout from Bausch & Lomb of a leading supplier of laboratory research models.
Wilson Greatbatch
Technologies 		$115 million leveraged buyout of a leading designer and manufacturer of power sources for implantable devices.
ABOUT | INVESTMENT FOCUS | PORTFOLIO | TEAM | NEWS
CONTACT | INVESTOR LOG-IN | TERMS OF USE | HOME